Glenn Welling Engaged Capital
Glenn Welling is the founder of Engaged Capital, an activist investment firm focused primarily on small- and mid-cap U.S. companies. Engaged Capital seeks undervalued businesses where operational improvement, cost discipline, or strategic change can unlock value. Welling’s campaigns are closely watched in the activist community for mid-market corporate engagement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cognex
CGNX
|
+$34.6M |
| 2 |
BlackLine
BL
|
+$24.5M |
| 3 |
VF Corp
VFC
|
+$5.98M |
| 4 |
GXO Logistics
GXO
|
+$4.19M |
| 5 |
Portillo's
PTLO
|
+$2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Evolent Health
EVH
|
+$1.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 46.43% |
| 2 | Technology | 15.41% |
| 3 | Consumer Staples | 13.7% |
| 4 | Industrials | 12.7% |
| 5 | Healthcare | 11.75% |
Similar funds
Glenn Welling's Q3 2025 Portfolio in Review
As of Q3 2025, Glenn Welling held 9 positions worth $408M, up 14% from $358M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Glenn Welling deployed $70.3M of net new capital in Q3 2025, opening 2 new positions and adding to 5 existing holdings. Its largest new stake was Cognex: 855,000 shares worth $38.7M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 46% of assets, down from 53% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Evolent Health, an estimated $1.85M trimmed.
- Glenn Welling's largest Q3 2025 buy was Cognex: 855,000 shares worth $38.7M.
- Glenn Welling added most to VF Corp in Q3 2025, an estimated $5.98M increase.
- Glenn Welling's biggest Q3 2025 reduction was Evolent Health, cutting an estimated $1.85M.
- Glenn Welling's ten largest holdings make up 100% of its $408M portfolio in Q3 2025.
- Glenn Welling opened 2 new positions and closed 0 in Q3 2025.
- Glenn Welling's portfolio value rose 14% quarter-over-quarter to $408M.
Based on Engaged Capital's 13F filing for Q3 2025, filed 14 Nov 2025.